Trial Profile
A Phase 1, Open-label Study in Healthy Female Subjects to Investigate the Drug-drug Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary) ; JNJ-5806 (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 31 Aug 2017 Status changed from recruiting to discontinued as study stopping rules were met.
- 28 Apr 2017 New trial record